A prospective, population-based study involving a cohort of 51,383 individuals from Norway has provided evidence that headache is a risk factor for vascular dementia (VaD) and mixed dementia, but not ...

Please provide your email address to receive an email when new articles are posted on . The study included almost 14,000 adult U.S women diagnosed with migraine who used contraceptives. Risks of ...

NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (DRUG) today announced compelling preclinical results for its investigational compound BMB‑201, in a validated isosorbide ...

Since migraine and Horton's syndrome present so many spontaneous variations in the course of their history, it has been the opinion of a group of those interested in headache 5 that final conclusions ...

THE migrainous patient is grateful for any medication that will afford him symptomatic relief. Until recently, about the only medication capable of offering him any appreciable degree of comfort was ...

You may have heard the terms “mixed tension headache,” "chronic daily headache," “chronic tension headache,” “mixed headache syndrome,” or “tension-vascular headache” before. Experts group all of ...

“BMB‑201 delivered strong and reproducible activity in a stringent vascular headache model, with efficacy signals that exceeded sumatriptan at multiple timepoints. This further validates the use of ...

• Robust efficacy versus vehicle at 1 and 2 hours in both sexes (periorbital von Frey thresholds). • Benchmark comparison: BMB‑201 showed greater effect sizes than sumatriptan at multiple timepoints ...

Headache is the chief complaint in 2-3% of patients on admission to emergency departments (EDs) in the United States – the fourth most common reason for an ED visit. The incidence of headaches with ...